Mannkind (MNKD) EBT Growth (1y) (2011 - 2026)
Mannkind (MNKD) EBT Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.10% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,140.26% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.57% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -220.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -220.19% |
| Dec 31, 2025 | -347.85% |
| Sep 30, 2025 | -39.54% |
| Jun 30, 2025 | 155.59% |
| Mar 31, 2025 | 25.00% |
| Dec 31, 2024 | 185.11% |
| Sep 30, 2024 | 647.82% |
| Jun 30, 2024 | 67.88% |
| Mar 31, 2024 | 211.22% |
| Dec 31, 2023 | 116.50% |
| Sep 30, 2023 | 111.92% |
| Jun 30, 2023 | 81.86% |
| Mar 31, 2023 | 62.32% |
| Dec 31, 2022 | 36.04% |
| Sep 30, 2022 | -226.07% |
| Jun 30, 2022 | 18.30% |
| Mar 31, 2022 | -101.29% |
| Dec 31, 2021 | -6.25% |
| Sep 30, 2021 | 61.42% |
| Jun 30, 2021 | -246.50% |